SavedAdd your journal

Journals / European Archives of Medical Research / 2022 / Cilt: 38 - Sayı: 1

Relationship Between Overactive Bladder and Anxiety in Young Men Population in Turkey

Fatih GÖKALP
Onur KARSLI
Bekir VOYVODA
Murat ÜSTÜNER
Ahmed Ömer HALAT
Ömür MEMİK
Pages
19–22
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The OAB-V8 symptom score in the group without anxiety (group 1) and the group with moderate anxiety (group 2) improved significantly at 1 month compared to the pre-treatment period (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Overactive bladder (OAB) symptoms affect quality of life.
📊
Key Findings & Data:Methods: Male patients aged 18-35 years, diagnosed with OAB between 2015 and 2020, were included in the study.
💡
Conclusion & Impact:The OAB-V8 symptom score in the group without anxiety (group 1) and the group with moderate anxiety (group 2) improved significantly at 1 month compared to the pre-treatment period (p
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Overactive bladder (OAB) symptoms affect quality of life. The current study evaluates the relationship between anxiety and OAB in young male patients in Turkish society. Methods: Male patients aged 18-35 years, diagnosed with OAB between 2015 and 2020, were included in the study. OAB query form (OAB-V8) was filled by participants. Hamilton anxiety scale (HAM-A) was used to evaluate the anxiety levels of OAB patients. OAB-V8 scores were compared statistically before and after anxiolytic treatment of anxious patients. Results: The mean age of 87 patients was 26.28±4.53 (95% confidence interval: 25.5-27.2) and the mean OAB-V8 symptom score was 24.96±5.7 (14-36). The OAB-V8 symptom score in the group without anxiety (group 1) and the group with moderate anxiety (group 2) improved significantly at 1 month compared to the pre-treatment period (p

🔖

Cite This Article

GÖKALP, F., KARSLI, O., VOYVODA, B., ÜSTÜNER, M., HALAT, A. Ö., MEMİK, Ö. (2022). Relationship Between Overactive Bladder and Anxiety in Young Men Population in Turkey. European Archives of Medical Research, Cilt: 38 - Sayı: 1, 19–22. https://ajindex.com/articles/510285

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, et al. Prevalence and burden of overactive bladder in the United States. World J Urol 2003;20:327-36
  2. Coyne KS, Sexton CC, Vats V, Thompson C, Kopp ZS, Milsom I. National community prevalence of overactive bladder in the United States stratified by sex and age. Urology 2011;77:1081-7
  3. Coyne KS, Kaplan SA, Chapple CR, Sexton CC, Kopp ZS, Bush EN, et al. Risk factors and comorbid conditions associated with lower urinary tract symptoms: EpiLUTS. BJU Int 2009;103(Suppl 3):24-32
  4. Coyne KS, Sexton CC, Irwin DE, Kopp ZS, Kelleher CJ, Milsom I. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int 2008;101:1388-95
  5. Bogner HR, Gallo JJ, Swartz KL, Ford DE. Anxiety disorders and disability secondary to urinary incontinence among adults over age 50. Int J Psychiatry Med 2002;32:141-54
  6. Felde G, Bjelland I, Hunskaar S. Anxiety and depression associated with incontinence in middle-aged women: a large Norwegian cross-sectional study. Int Urogynecol J 2012;23:299-306
  7. Tarcan T, Mangır N, Özgür MÖ, Akbal C. OAB-V8 Overactive bladder questionnaire validation study. Üroloji Bülteni 2012;21:113-6
  8. Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC. Twelvemonth use of mental health services in the United States: results from the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:629-40
  9. Freeman RM, McPherson FM, Baxby K. Psychological features of women with idiopathic detrusor instability. Urol Int 1985;40:257-9
  10. Zorn BH, Montgomery H, Pieper K, Gray M, Steers WD. Urinary incontinence and depression. J Urol 1999;162:82-4
  11. Klausner AP, Steers WD. Corticotropin releasing factor: a mediator of emotional influences on bladder function. J Urol 2004;172:2570-3
  12. Milsom I, Kaplan SA, Coyne KS, Sexton CC, Kopp ZS. Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS. Urology 2012;80:90-6
  13. Lai HH, Vetter J, Jain S, Andriole GL. Systemic nonurological symptoms in patients with overactive bladder. J Urol 2016;196:467-72
  14. Alves AT, Jácomo RH, Gomide LB, Garcia PA, Bontempo AP, Karnikoskwi MG. Relationship between anxiety and overactive bladder syndrome in older women. Rev Bras